The field of angiogenesis began in the early 1970s when Judah Folkman proposed that tumor growth would be halted if the tumor were deprived of a blood supply. Thirty years later, Folkman's controversial idea is now widely accepted and angiogenesis inhibitors hold great promise for the treatment of cancer.

You do not currently have access to this content.